- Rosetta Genomics, Prime Health Reach Deal for Coverage of MiRview Mets2 Assay
May 20, 2013 / GenomeWeb Daily News
- New York Gives Final Approval for Rosetta Genomics' miRview Lung Assay
November 6, 2012 / GenomeWeb Daily News
- Rosetta to Offer $35M in Public Offering, Receives NYS Approval for Lung Cancer Assay
June 26, 2012 / GenomeWeb Daily News
- Rosetta Genomics, Pace Ally on Mesothelioma Test Marketing, Services
June 14, 2011 / GenomeWeb Daily News
- Sanra Labs Makes Full Payment to Rosetta Genomics, Settling Dispute
May 10, 2013 / GenomeWeb Daily News